See All News - tctmd.com

News

News Industry News

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

April 04, 2011

News Industry News

St. Jude Medical Receives FDA Approval for New Bi-Directional Ablation Catheters

April 04, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

April 04, 2011

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

News Conference News

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

April 04, 2011

News Conference News

Radial vs. Femoral Angioplasty: Still RIVALs

Jason Kahn

April 04, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Industry News

AngioScore Launches New Longer AngioSculpt(R) Devices For Treatment Of Peripheral Artery Disease

April 03, 2011

News Conference News

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

Jason Kahn

April 03, 2011

Advertisement

News

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

St. Jude Medical Receives FDA Approval for New Bi-Directional Ablation Catheters

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

Radial vs. Femoral Angioplasty: Still RIVALs

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

AngioScore Launches New Longer AngioSculpt(R) Devices For Treatment Of Peripheral Artery Disease

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

Search News

Advertisement

Advertisement

News

Search News

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content